Company / Free Cash Flow per Share
Gilead Sciences Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$7.59
FY2025
5-year range
$6.00 / $8.66
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#13 of 192
Health Care
What the data says
Among 192 Health Care companies, Gilead Sciences is in the top 7% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $5.94 in FY2020 to $15.65 in FY2017.
Based on SEC 10-K filings.
7.59 in FY2025 with a 5-year CAGR of +5.0%. Top quartile in the Health Care sector.
Declined from $8.66 to $7.59 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +8.2%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Sector benchmark
+138.3% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 8.2% year-over-year.
- Ranks #13 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.59 | -8.2% |
| FY2024 | $8.27 | -4.6% |
| FY2023 | $8.66 | +44.5% |
| FY2022 | $6.00 | -9.6% |
| FY2021 | $6.63 | +11.7% |
| FY2020 | $5.94 | -32.7% |
| FY2019 | $8.82 | -29.2% |
| FY2018 | $12.46 | -20.4% |
| FY2017 | $15.65 | +81.5% |
| FY2016 | $8.62 | -37.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026